logologo
Search stocks, ETFs, IPOs & more
Quest
arrow
WhatsApp Icon

Park Medi World share price jumps 8% ahead of Q1FY27

PARKHOSPS

Park Medi World Ltd

PARKHOSPS

Ask AI

Ask AI

Stock rallies ahead of June-quarter numbers

Park Medi World shares saw strong buying interest ahead of the company’s June-quarter (Q1FY27) financial results. The hospital chain’s stock was reported up nearly 5% after an update related to the first-quarter results for FY2026-27. At around 3:20 pm, the stock was trading 4.28% higher at Rs 291.05 on the BSE, with a market capitalisation of Rs 12,571.35 crore. Another market snapshot in the provided data also cited the current share price around Rs 295.35.

The move comes as investors position ahead of the company’s scheduled results announcement and the follow-up interaction with analysts and institutional investors. The stock has been in focus after reporting record quarterly and annual metrics in FY26.

Intraday move: close to record levels

On Friday, 31 July, Park Medi World jumped more than 8% in intraday trade on the BSE ahead of the June-quarter results. The stock opened at Rs 282.95 versus the previous close of Rs 279.10 and rose as much as 8.2% to an intraday high of Rs 301.95. That placed it near its record high of Rs 305.25, which was hit on 1 July.

The provided data also listed key trading levels such as “Today’s High” at Rs 305.25 and “Today’s Low” at Rs 290. It also showed a 52-week high of Rs 303.3 and a 52-week low of Rs 138.15. These levels indicate the stock has been trading near the upper end of its one-year range.

What the company told exchanges

The company’s exchange filing indicated that its board of directors would meet to consider and approve standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The text includes two different references for the board meeting date: one update cited Tuesday, August 4, while another exchange filing dated 29 July said the board meeting was scheduled for Monday, August 3.

Separately, the company informed that a conference call for analysts and institutional investors is scheduled on Tuesday, August 4, 2026 at 09:00 am IST. The call is meant to discuss the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026.

Key dates investors are tracking

The near-term focus is on the Q1FY27 result announcement and the related management commentary. With the call scheduled for August 4 morning, the market will watch for updates on operational performance, margins, and any integration benefits from acquisitions mentioned in the FY26 context.

The provided “Quick Details” section also listed the results date as August 03, 2026 for Q1 FY 2026-2027, alongside summary financial indicators from the prior quarter.

FY26 ended with record quarterly and annual performance

Park Medi World had reported record revenue, profit, and EBITDA for Q4FY26 as well as for the full financial year FY26. For Q4FY26, it recorded revenue of Rs 460.40 crore, up 30% year-on-year. Net profit for the quarter was Rs 76.8 crore, up 47% year-on-year, with net profit margin rising 188 bps year-on-year to 16.7%.

EBITDA for Q4FY26 was Rs 127.4 crore, up 44% year-on-year, and EBITDA margin stood at 27.7%, up 268 bps year-on-year. These numbers set the reference point for what investors may look for in Q1FY27, especially on margins and growth consistency.

Full-year FY26: revenue and profit snapshot

For FY26, revenue rose 21% year-on-year to Rs 1,679.4 crore, while net profit increased 27% year-on-year to Rs 273.6 crore. Net profit margin for the year improved by 83 bps year-on-year to 16.3%. EBITDA was Rs 444.3 crore, up 20% year-on-year, with an EBITDA margin of 26.5%.

The text also presented the same FY26 performance in INR millions, which converts to the crore figures above: revenue from operations at Rs 1,679.356 crore (Rs 16,793.56 million) and consolidated net profit at Rs 273.557 crore (Rs 2,735.57 million). It attributed the revenue increase to the inclusion of newly acquired subsidiaries and expansion of healthcare services. The board approved audited financial results at its meeting held on May 12, 2026.

Debt and key metrics highlighted in summaries

A “Quick Details” snapshot cited net debt (latest quarter) at Rs 28 crore. It also listed market cap at Rs 12,083.27 crore and CMP at Rs 279.25 at that time. These figures provide a reference for how the market was valuing the company around the results window, though the market cap and price varied across timestamps in the provided text.

Some additional platform metrics in the data included EPS (TTM) at Rs 0.85, ROE at 6.51%, and ROCE at 8.47%. The same dataset also mentioned profit growth of -4.22% and separately noted poor profit growth of about -4.92% over the past three years. These are presented as platform-reported metrics in the supplied content.

Key facts table

ItemValue (as stated in provided text)
Intraday high (31 July)Rs 301.95
Record high mentionedRs 305.25 (hit on 1 July)
Price at ~3:20 pm (BSE)Rs 291.05 (+4.28%)
Market cap at ~3:20 pmRs 12,571.35 crore
Q4FY26 revenueRs 460.40 crore
Q4FY26 net profit (PAT)Rs 76.8 crore
Q4FY26 EBITDA margin27.7%
FY26 revenueRs 1,679.4 crore
FY26 net profitRs 273.6 crore
Net debt (latest quarter)Rs 28 crore
Analyst callAug 4, 2026, 09:00 am IST

Market impact and what to watch next

The immediate market driver in the article is the scheduled Q1FY27 results and management interaction, which often shapes near-term sentiment for hospital and healthcare services stocks. The stock’s move toward prior highs suggests traders are reacting not only to the date confirmation but also to the strong FY26 exit quarter that featured record revenue, profit, and EBITDA.

Investors will likely compare Q1FY27 operating metrics against the Q4FY26 base, where net profit margin was 16.7% and EBITDA margin was 27.7%. They will also track how net debt trends from the cited Rs 28 crore figure and whether the company reiterates any expansion or integration commentary tied to its subsidiaries.

Conclusion

Park Medi World shares rallied into the Q1FY27 results window as the company outlined its board meeting schedule and confirmed an analyst and institutional investor call for August 4, 2026. With FY26 ending on record revenue of Rs 1,679.4 crore and net profit of Rs 273.6 crore, the upcoming June-quarter print and the management call are the next confirmed milestones for the stock.

Frequently Asked Questions

The stock gained as the company updated exchanges about the schedule for approving Q1FY27 unaudited results and confirmed an analyst and institutional investor call on August 4, 2026.
The provided text mentions a board meeting to consider Q1FY27 results, cited as August 3, 2026 in one filing and August 4, 2026 in another update, with an analyst call on August 4, 2026.
Q4FY26 revenue was Rs 460.40 crore and net profit was Rs 76.8 crore, with an EBITDA margin of 27.7% and net profit margin of 16.7%.
FY26 revenue rose 21% year-on-year to Rs 1,679.4 crore and net profit increased 27% year-on-year to Rs 273.6 crore, with EBITDA of Rs 444.3 crore.
A summary in the provided content cited net debt (latest quarter) at Rs 28 crore.

Did your stocks survive the war?

See what broke. See what stood.

Live Q1 Earnings Tracker